Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have pleiotropic effects, including preventing the development and progression of coronary atherosclerosis, epicardial coronary artery vasospasms, and structural/functional changes in coronary microvasculature. Here, GLP1R is linked to coronary atherosclerosis.